GO
Loading...

Government Agencies

More

  • Professors object to FAA restrictions on drone use Sunday, 27 Jul 2014 | 10:27 PM ET

    The FAA allows hobbyists to use model aircraft or small drones so long as they keep them away from airports, fly them under 400 feet and keep the aircraft within sight of the remote-controlling operator at all times.

  • Goldman mortgage deal could reach $1.25B: Source Saturday, 26 Jul 2014 | 1:59 PM ET

    The FHFA filed 18 lawsuits against Goldman and other banks in 2011 over about $200 billion in mortgage-backed securities that later went sour.

  • NEW YORK, July 26- A deal to resolve a U.S. regulator's claims against Goldman Sachs Group Inc over mortgage-backed securities sold to Fannie Mae and Freddie Mac leading up to the financial crisis could cost the bank between $800 million and $1.25 billion, according to a person familiar with the matter.

  • WASHINGTON, July 25- The U.S. House Financial Services Committee said on Friday that it will vote on a bill next week aimed at bringing more transparency to the Federal Reserve, including the controversial requirement of adopting a rules-based approach to its policy.

  • New rules bother employers—Obamacare not as much Friday, 25 Jul 2014 | 2:57 PM ET
    President Barack Obama delivers remarks during the White House Summit on Working Families at the Omni Shoreham in June.

    Additional rules and enforcement from federal agencies have a majority of employers worried about how to run their firms.

  • NEW YORK, July 25- Even if data next week shows a mediocre rebound in U.S. economic growth, that might be enough to keep the stock market aloft at record highs and the Federal Reserve steadfast in its winding down of stimulus through bond purchases.

  • WASHINGTON, July 25- The U.S. Federal Reserve on Friday approved a resubmitted capital plan from Zions Bancorporation, part of an annual stress test of banks' financial robustness. In March, the Fed objected to the bank's 2014 capital plan because it did not meet the minimum 5 percent capital requirement in a simulated economic downturn.

  • FEDERAL RESERVE SAYS IT HAS NOT OBJECTED TO RESUBMITTED CAPITAL PLAN FROM ZIONS BANCORPORATION.

  • President Barack Obama said on Thursday the Federal Reserve was "properly focused" on unemployment given the relatively tame pace of inflation in the country, offering a broad endorsement of Fed Chair Janet Yellen's policy approach.

  • Obama: FAA took 'prudent action' on Israel flights Thursday, 24 Jul 2014 | 5:49 PM ET

    He noted that the FAA ban came on the heels of last week's downing of a passenger jet by a missile in eastern Ukraine. Obama says that before lifting the ban, the FAA worked with Israel on a "checklist of concerns and mitigation measures" to ensure the safety of U.S. airlines. The FAA said the ban was imposed out of concern for the risk of planes being hit by Hamas rockets.

  • FDA reviewing what could be first biosimilar drug Thursday, 24 Jul 2014 | 3:41 PM ET

    Nearly five years after Congress passed a law enabling future approval of biosimilars, for the first time the FDA has accepted an application to sell a similar, but not identical, version of a biologic drug.

  • Reversing a lower court ruling, the 2nd U.S. Circuit Court of Appeals in New York said the FDA was empowered to reject two citizen challenges to its policy, which discourages but does not ban the use of penicillin and some tetracyclines in feed for chickens, cows and pigs, even if they are not sick.

  • Reversing a lower court ruling, the 2nd U.S. Circuit Court of Appeals in New York said the FDA was empowered to reject two citizen challenges to its policy, which discourages but does not ban the use of penicillin and some tetracyclines in feed for chickens, cows and pigs, even if they are not sick.

  • Senior US Homeland Security cyber official to retire Thursday, 24 Jul 2014 | 8:06 AM ET
    Director of Homeland Security Department's National Cybersecurity and Communications Integration Center Larry Zelvin testifies before the House Energy and Commerce Subcommittee on protecting consumer information, in Washington.

    Larry Zelvin, the Homeland Security head who helped secure banks from cyberattacks and erect defenses after the Target breach, is retiring.

  • Cruz demands answers on FAA flight ban to Israel Thursday, 24 Jul 2014 | 12:30 AM ET

    Ted Cruz vowed Thursday to continue blocking confirmation of a series of ambassadorial and other diplomatic nominees despite the Federal Aviation Administration lifting a ban on U.S. airline flights to Israel.

  • FDA approves new painkiller from OxyContin maker Wednesday, 23 Jul 2014 | 5:45 PM ET

    FDA regulators approved the drug for daily, round-the-clock pain that does not respond to other medications. The FDA notes that Targiniq can still be abused by simply swallowing the tablets, the most frequent method of painkiller abuse. The FDA has been under intense public pressure to combat the national epidemic of prescription opioid abuse.

  • FDA warns of compounded drug recall by Texas firm Wednesday, 23 Jul 2014 | 3:25 PM ET

    WASHINGTON— The Food and Drug Administration warned doctors Wednesday not to use compounded drugs from a Texas specialty pharmacy due to potential risks of contamination. The agency says FDA inspectors recently uncovered unsanitary conditions at Unique Pharmaceuticals' plant in Temple, Texas.

  • July 23- The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences Inc's Zydelig, a drug to treat three types of blood cancer. The FDA approved the use of Zydelig in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.

  • FDA approves Gilead Sciences drug for 3 cancers Wednesday, 23 Jul 2014 | 12:57 PM ET

    WASHINGTON— The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer. The FDA has approved three other drugs for the disease in the last year: Roche's Gazyva, Janssen Pharmaceutical's Imbruvica and GlaxoSmithKline's Arzerra.

  • U.S. FDA approves Gilead's blood cancer drug Zydelig Wednesday, 23 Jul 2014 | 12:05 PM ET

    July 23- The U.S. Food and Drug Administration has approved Gilead Inc's drug Zydelig to treat three types of blood cancer, the agency said on Wednesday. The FDA approved it for use in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.